US 9181253
Adenosine receptor agonists, partial agonists, and antagonists
granted A61KA61K31/52A61P
Quick answer
US patent 9181253 (Adenosine receptor agonists, partial agonists, and antagonists) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/52, A61P, A61P25/00, A61P25/08